AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

BUSINESS BRIEFS.(TO THE POINT)

Investor's Business Daily

| February 02, 2004 | COPYRIGHT 2004 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

MEDICAL

Beckham Coulter cautious on Q1

The lab equipment maker made 90 cents a share ex items in Q4, flat with views and matching a year ago, on a 7% rise in sales. Beckham also narrowed its Q1 forecast to 48-52 cents a share. Views were for 51 cents a share. Shares fell 1%.

Lexapro patients may pay more

Health insurers Wellpoint, Humana and Health Net are considering making it more expensive for patients to buy Forest Lab's anti-depressant Lexapro once generic versions of predecessor drug Celexa are out in '04. The HMOs say there's no big difference in the 2 drugs; Forest disagrees. Lexapro had $314 mil in sales in Forest's most recent quarter. Forest fell 1%.

Eyetech soars on 1st trading day

The biotech, which makes Macugen, a drug to curb age-related blindness, closed its first day of trading at 32.40, a 54% rise over its IPO price of $21. Macugen, which is being co-developed with Pfizer, is in phase three testing and is estimated to garner $1 bil sales upon FDA approval.

Related articles from newspapers, magazines, journals, and more
TCG LifeSc, Forest Lab in drug discovery pact.
News wire article from: PTI - The Press Trust of India Ltd. June 18, 2007 700+ words
TCG LifeSc, Forest Lab in drug discovery pact New Delhi, June 18 (PTI): TCG Lifesciences...fill our early stage pipeline through discovery partnerships," Forest Lab Inc Senior Vice-President Scientific Affairs Ivan Gergel said...
Lupin enters into marketing alliance with Forest Lab.
News wire article from: PTI - The Press Trust of India Ltd. August 19, 2008 700+ words
Lupin enters into marketing alliance with Forest Lab Mumbai, Aug 19 (PTI) Pharma major Lupin Ltd today said...marketing management for AeroChamber Plus line of products with Forest Lab Inc. The product will be promoted among pediatricians through...
Aurigene, Forest Lab forge collaboration agreement.
News wire article from: PTI - The Press Trust of India Ltd. February 3, 2007 700+ words
Aurigene, Forest Lab forge collaboration agreement Bangalore, Feb 2 (PTI) Bangalore-based discovery services company, Aurigene Discovery Technologies...
News and FDA Updates for ZOLL (Nasdaq:ZOLL), Forest Lab (NYSE:FRX), BioDelivery...
Press release article from: M2 Presswire August 20, 2009 700+ words
M2 PRESSWIRE-20 August 2009-BiomedReports: News and FDA Updates for ZOLL (Nasdaq:ZOLL), Forest Lab (NYSE:FRX), BioDelivery Scs (Nasdaq:BDSI), Weikang Bio-Tech (OTC:WKBT)(C)1994-2009 M2 COMMUNICATIONS RDATE...
Forest Lab's 1st-qtr net revenues leap 15%.(Forest Laboratories )(Financial...
Newspaper article from: Pharma Marketletter July 24, 2006 700+ words
US drugmaker Forest Laboratories says that net revenues for its fiscal first quarter ended June 30, 2006, increased 15% to $816.3 million on the year-ago period. Net revenues were comprised of net sales, which were up 12% to $758,768,000 from $674.7 million. Net income, however, was down 7.4% at
AstraZeneca, Forest Lab in ceftaroline deal.(Thursday, August 13)
Newspaper article from: BioWorld Week August 17, 2009 700+ words
Making headlines for the second time this week, Forest Laboratories Inc., of New York, signed AstraZeneca plc to an ex-North American partnership for late-stage antibiotic ceftaroline, though the drug still faces regulatory hurdles in the U.S. That deal, coming a few days after Forest agreed to pay
Neurobiological Technologies, Inc. Reports FDA Has Accepted Forest Lab's sNDA...
Press release article from: PR Newswire November 15, 2004 700+ words
Neurobiological Technologies, Inc. , a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates, today reports that the U.S. Food and Drug Administration has accepted Forest Laboratories' filing of a supplemental New Drug
Comcast Net Up, but Shares Down on Subscriber Loss; Comcast posts a 28 percent...
Magazine article from: eWeek Adegoke, Yinka July 26, 2007 700+ words
...quarterly profit on Thursday, but its shares fell nearly 7 percent as it lost more subscribers...sales in June. Time Warner Cable Inc. shares fell by 6.3 percent while Cablevision Systems...had broken the $100-mark. Comcast shares fell 6.6 percent to $26.66 in mid...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA